Non-Saccharomyces yeasts protect against epithelial cell barrier disruption induced by Salmonella enterica subsp. enterica serovar Typhimurium

Badia, 2012, β-galactomannan and Saccharomyces cerevisiae var. boulardii modulate the immune response against Salmonella enterica serovar typhimurium in porcine intestinal epithelial and dendritic cells, Clin Vaccine Immunol, 19, 368, 10.1128/CVI.05532-11

Canonici, 2012, Saccharomyces boulardii improves intestinal epithelial cell restitution by inhibiting αvβ5 integrin activation state, PLoS ONE, 7, e45047, 10.1371/journal.pone.0045047

Clayburgh, 2004, A porous defense: the leaky epithelial barrier in intestinal disease, Lab Invest, 84, 282, 10.1038/labinvest.3700050

Czerucka, 2000, Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells, Infect Immun, 68, 5998, 10.1128/IAI.68.10.5998-6004.2000

Edwards-Ingram, 2007, Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae, Appl Environ Microbiol, 73, 2458, 10.1128/AEM.02201-06

Fang, 2010, Inhibitory effects of Lactobacillus casei subsp. rhamnosus on Salmonella lipopolysaccharide-induced inflammation and epithelial barrier dysfunction in a co-culture model using Caco-2/peripheral blood mononuclear cells, J Med Microbiol, 59, 573, 10.1099/jmm.0.009662-0

Gagnon, 2013, Comparison of the Caco-2, HT-29 and the mucus-secreting HT29-MTX intestinal cell models to investigate Salmonella adhesion and invasion, J Microbiol Methods, 94, 274, 10.1016/j.mimet.2013.06.027

Gedek, 1999, Adherence of Escherichia coli serogroup O 157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii, Mycoses, 42, 261, 10.1046/j.1439-0507.1999.00449.x

Haraga, 2008, Salmonellae interplay with host cells, Nat Rev Microbiol, 6, 53, 10.1038/nrmicro1788

Jepson, 1995, Rapid disruption of epithelial barrier function by Salmonella typhimurium is associated with structural modification of intercellular junctions, Infect Immun, 63, 356, 10.1128/IAI.63.1.356-359.1995

Klingberg, 2005, Application of measurements of transepithelial electrical resistance of intestinal epithelial cell monolayers to evaluate probiotic activity, Appl Environ Microbiol, 71, 7528, 10.1128/AEM.71.11.7528-7530.2005

Klingberg, 2008, Comparison of Saccharomyces cerevisiae strains of clinical and nonclinical origin by molecular typing and determination of putative virulence traits, FEMS Yeast Res, 8, 631, 10.1111/j.1567-1364.2008.00365.x

Kumura, 2004, Screening of dairy yeast strains for probiotic applications, J Dairy Sci, 87, 4050, 10.3168/jds.S0022-0302(04)73546-8

Lebeer, 2010, Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens, Nat Rev Microbiol, 8, 171, 10.1038/nrmicro2297

Maccaferri, 2012, Potential probiotic Kluyveromyces marxianus B0399 modulates the immune response in Caco-2 cells and peripheral blood mononuclear cells and impacts the human gut microbiota in an in vitro colonic model system, Appl Environ Microbiol, 78, 956, 10.1128/AEM.06385-11

Mankertz, 2007, Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications, Curr Opin Gastroenterol, 23, 379, 10.1097/MOG.0b013e32816aa392

Martins, 2007, Saccharomyces cerevisiae strain 905 reduces the translocation of Salmonella enterica serotype Typhimurium and stimulates the immune system in gnotobiotic and conventional mice, J Med Microbiol, 56, 352, 10.1099/jmm.0.46525-0

Martins, 2010, Interaction of Saccharomyces boulardii with Salmonella enterica serovar Typhimurium protects mice and modifies T84 cell response to the infection, PLoS ONE, 5, e8925, 10.1371/journal.pone.0008925

Mennigen, 2009, Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis, Am J Physiol Gastrointest Liver Physiol, 296, G1140, 10.1152/ajpgi.90534.2008

Pedersen, 2012, Biodiversity and probiotic potential of yeasts isolated from Fura, a West African spontaneously fermented cereal, Int J Food Microbiol, 159, 144, 10.1016/j.ijfoodmicro.2012.08.016

Peterson, 2014, Intestinal epithelial cells: regulators of barrier function and immune homeostasis, Nat Rev Immunol, 14, 141, 10.1038/nri3608

Pontier-Bres, 2012, Modification of Salmonella Typhimurium motility by the probiotic yeast strain Saccharomyces boulardii, PLoS ONE, 7, e33796, 10.1371/journal.pone.0033796

Romanin, 2010, Down-regulation of intestinal epithelial innate response by probiotic yeasts isolated from kefir, Int J Food Microbiol, 140, 102, 10.1016/j.ijfoodmicro.2010.04.014

Saegusa, 2007, Cytokine responses of intestinal epithelial-like Caco-2 cells to non-pathogenic and opportunistic pathogenic yeasts in the presence of butyric acid, Biosci Biotechnol Biochem, 71, 2428, 10.1271/bbb.70172

Seth, 2008, Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism, Am J Physiol Gastrointest Liver Physiol, 294, G1060, 10.1152/ajpgi.00202.2007

Smith, 2014, Yeast modulation of human dendritic cell cytokine secretion: an in vitro study, PLoS ONE, 9, e96595, 10.1371/journal.pone.0096595

Sultana, 2013, Strain-dependent augmentation of tight-junction barrier function in human primary epidermal keratinocytes by Lactobacillus and Bifidobacterium lysates, Appl Environ Microbiol, 79, 4887, 10.1128/AEM.00982-13

Suzuki, 2013, Regulation of intestinal epithelial permeability by tight junctions, Cell Mol Life Sci, 70, 631, 10.1007/s00018-012-1070-x

Tiago, 2009, Physiological characterization of non-Saccharomyces yeasts from agro-industrial and environmental origins with possible probiotic function, World J Microbiol Biotechnol, 25, 657, 10.1007/s11274-008-9934-9

Tiago, 2012, Adhesion to the yeast cell surface as a mechanism for trapping pathogenic bacteria by Saccharomyces probiotics, J Med Microbiol, 61, 1194, 10.1099/jmm.0.042283-0

Turner, 2009, Intestinal mucosal barrier function in health and disease, Nat Rev, 9, 799

Aa Kühle, 2003, The taxonomic position of Saccharomyces boulardii as evaluated by sequence analysis of the D1/D2 domain of 26S rDNA, the ITS1-5.8S rDNA-ITS2 region and the mitochondrial cytochrome-c oxidase II gene, Syst Appl Microbiol, 26, 564, 10.1078/072320203770865873

Zihler, 2011, Protective effect of probiotics on Salmonella infectivity assessed with combined in vitro gut fermentation-cellular models, BMC Microbiol, 11, 264, 10.1186/1471-2180-11-264